Skip to main content
Premium Trial:

Request an Annual Quote

DNAVision, BioXpr Integrate Genetic Analysis, Informatics

NEW YORK (GenomeWeb News) – DNAVision said today that it has teamed with BioXpr to offer an integrated genetic analysis and bioinformatics platform.

The company said that the offering will cover design, experimentation, analysis, and interpretation of microarray-based research projects focused on drug discovery and development.

BioXpr, a spin-off from Namur University in Belgium, offers bioinformatics solutions used in collecting, storing, extracting, and analyzing data from high-throughput experiments, clinical trials, databases, and literature. DNAVision offers a range of services and technologies, including nucleic acids extraction, expression profiling, SNP genotyping, and DNA sequencing.

BioXpr CEO Benjamin Damien said in a statement that the platform "will create an ideal environment to easily integrate genomics data into systems biology."

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.